Sun Pharma Inds. Financial Results

Q: What are the Net Sales of Sun Pharma Inds in the financial year 2026?

For FY 2026 , Sun Pharma Inds recorded Net Sales of ₹ 58462.04 crores .This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

Q: What is the Operating Profit of Sun Pharma Inds in 2026?

The Operating Profit of Sun Pharma Inds for FY 2026 is ₹ 19703.12 crores . With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

Q: What is the Profit Before Tax (PBT) of Sun Pharma Inds in 2026?

In FY 2026 , Sun Pharma Inds posted a Profit Before Tax of ₹ 15118.88 crores It helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

Q: What is the Net Profit of Sun Pharma Inds for 2026?

Sun Pharma Inds recorded a Net Profit of ₹ 11564.52 crores in FY 2026 . It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

Q: What is the Face Value of Sun Pharma Inds?

The Face Value of Sun Pharma Inds shares is 1 .It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

Q: What is the PAT Margin (PATM%) of Sun Pharma Inds in 2026?

In FY 2026 , the PAT Margin of Sun Pharma Inds is 19.78 % . This metric provides insights into the company's efficiency in generating profits after paying taxes.

BSE Code: 524715|NSE Symbol:SUNPHARMA|ISIN: INE044A01036

1845 6.7(0.36)

Open (Rs) 1845

Close (Rs) 1838.3

High (Rs) 1865.2

Low (Rs) 1834

Face Value1

Market Capital (Cr.)442677.31

Daily Volume1588758

Life Time High1952.25

Life Time Low151.1

52 Week High1916.6

52 Week Low1548

Results

Consolidated

IN CR	MAR 2026	MAR 2025	MAR 2024	MAR 2023	MAR 2022	MAR 2021
Net Sales	58,462.04	52,578.44	48,496.85	43,885.68	38,654.49	33,498.14
Total Expenditure	40,730.64	37,492.28	35,509.85	32,238.89	28,410.73	25,030.42
PBIDT (Excl OI)	17,731.40	15,086.16	12,987.00	11,646.79	10,243.76	8,467.72
Other Income	1,971.72	2,150.57	1,390.32	634.52	1,075.47	859.17
Operating Profit	19,703.12	17,236.73	14,377.32	12,281.31	11,319.23	9,326.89
Interest	338.91	231.36	238.47	172.00	127.35	141.43
Exceptional Items	-1,307.48	-677.85	-494.32	-171.45	-4,566.82	-4,306.14
PBDT	18,056.73	16,327.52	13,644.53	11,937.86	6,625.06	4,879.32
Depreciation	2,937.85	2,575.39	2,556.64	2,529.43	2,143.74	2,079.95
Profit Before Tax	15,118.88	13,752.13	11,087.89	9,408.43	4,481.32	2,799.37
Tax	3,554.36	2,772.03	1,439.45	847.59	1,075.50	514.69
Provisions and contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Profit After Tax	11,564.52	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Prior Period Expenses	0.00	0.00	0.00	0.00	0.00	0.00
Other Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	11,564.52	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
Equity Capital	239.93	239.93	239.93	239.93	239.93	239.93
Face Value (IN RS)	1.00	1.00	1.00	1.00	1.00	1.00
Reserves	83,330.16	71,978.09	63,426.82	55,755.45	47,771.29	46,222.85
Basic Eps After Extraordinary Items	47.84	45.55	39.91	35.32	13.64	12.10
Basic Eps Before Extraordinary Items	47.84	45.55	39.91	35.32	13.64	12.10
No of Public Share Holdings	0.00	0.00	0.00	0.00	0.00	0.00
% of Public Share Holdings	0.00	0.00	0.00	0.00	0.00	0.00
PBIDTM% (Excl OI)	30.33	28.69	26.78	26.54	26.50	25.28
PBIDTM%	33.70	32.78	29.65	27.98	29.28	27.84
PBDTM%	30.89	31.05	28.13	27.20	17.14	14.57
PBTM%	25.86	26.16	22.86	21.44	11.59	8.36
PATM%	19.78	20.88	19.89	19.51	8.81	6.82

FAQs

What are the Net Sales of Sun Pharma Inds in the financial year 2026?

For FY 2026, Sun Pharma Inds recorded Net Sales of ₹58462.04 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

What is the Operating Profit of Sun Pharma Inds in 2026?

The Operating Profit of Sun Pharma Inds for FY 2026 is ₹19703.12 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

What is the Profit Before Tax (PBT) of Sun Pharma Inds in 2026?

In FY 2026, Sun Pharma Inds posted a Profit Before Tax of ₹15118.88 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

What is the Net Profit of Sun Pharma Inds for 2026?

Sun Pharma Inds recorded a Net Profit of ₹11564.52 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

What is the Face Value of Sun Pharma Inds?

The Face Value of Sun Pharma Inds shares is 1.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

What is the PAT Margin (PATM%) of Sun Pharma Inds in 2026?

In FY 2026, the PAT Margin of Sun Pharma Inds is 19.78 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

How to open a Demat Account with Anand Rathi to invest in Sun Pharma Inds?

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Sun Pharma Inds using our TradeMobi App or Web Trading Platform.